Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

Counterregulation between the Fc RI Pathway and Antiviral Responses in Human Plasmacytoid Dendritic Cells

(2010) M. A. Gill et al.   JOURNAL OF IMMUNOLOGY

Role of viral respiratory infections in asthma and asthma exacerbations

(2010) William W Busse et al.   LANCET

Relationship between pretreatment specific IgE and the response to omalizumab therapy

(2009) U. Wahn et al.   ALLERGY

An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

(2009) Helen K. Reddel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Safety and tolerability of omalizumab

(2009) J. Corren et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma

(2009) Bob Lanier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population

(2009) James E Gern et al.   BMC Pulmonary Medicine

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial

(2008) Stanley J Szefler et al.   LANCET

Basal Cells of Differentiated Bronchial Epithelium Are More Susceptible to Rhinovirus Infection

(2007) Bogdan Jakiela et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY